SLC6A3 and Parkinson disease: In a recent study using data from sequential DAT-SPECT imaging in 344 PD patients from the PPMI dataset, Liu and colleagues demonstrated a significant association between DAT binding both at baseline and at follow-up scans and several baseline non-motor symptoms, with RBD showing the strongest association with concurrent and future DAT binding [270].